News | January 14, 2025
Cube Biotech acquires IBA Lifesciences
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
There was no casualty or loss of human life in the incidence
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug conjugate (ADC)
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL
Subscribe To Our Newsletter & Stay Updated
